52 related articles for article (PubMed ID: 34164479)
21. Oral mucositis in childhood cancer patients receiving high-dose methotrexate: Prevalence, relationship with other toxicities and methotrexate elimination.
Valer JB; Curra M; Gabriel AF; Schmidt TR; Ferreira MBC; Roesler R; Evangelista JMC; Martins MAT; Gregianin L; Martins MD
Int J Paediatr Dent; 2021 Mar; 31(2):238-246. PubMed ID: 32815183
[TBL] [Abstract][Full Text] [Related]
22. Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination.
Zhang J; Wang H; Fan Y; Yu Z; You G
Pharmacol Ther; 2021 Jan; 217():107647. PubMed ID: 32758646
[TBL] [Abstract][Full Text] [Related]
23. Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions.
Antonescu IE; Karlgren M; Pedersen ML; Simoff I; Bergström CAS; Neuhoff S; Artursson P; Steffansen B; Nielsen CU
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32344570
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacogenetics of high-dose methotrexate in Chinese adult patients with non-Hodgkin lymphoma: a population analysis.
Yang L; Wu H; de Winter BCM; Sheng CC; Qiu HQ; Cheng Y; Chen J; Zhao QL; Huang J; Jiao Z; Xie RX
Cancer Chemother Pharmacol; 2020 May; 85(5):881-897. PubMed ID: 32246190
[TBL] [Abstract][Full Text] [Related]
25. Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples.
Karami F; Ranjbar S; Ghasemi Y; Negahdaripour M
J Pharm Anal; 2019 Dec; 9(6):373-391. PubMed ID: 31890337
[TBL] [Abstract][Full Text] [Related]
26. Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis.
Tang H; Wu YJ; Xiao F; Wang B; Asenso J; Wang Y; Sun W; Wang C; Wei W
Biomed Pharmacother; 2019 Nov; 119():109432. PubMed ID: 31521892
[TBL] [Abstract][Full Text] [Related]
27. The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule.
Fan J; Chen L; Lu X; Li M; Zhu L
AAPS PharmSciTech; 2019 Jul; 20(6):247. PubMed ID: 31286321
[TBL] [Abstract][Full Text] [Related]
28. Zebrafish (Danio rerio) Oat1 and Oat3 transporters and their interaction with physiological compounds.
Dragojević J; Mihaljević I; Popović M; Smital T
Comp Biochem Physiol B Biochem Mol Biol; 2019 Oct; 236():110309. PubMed ID: 31255699
[TBL] [Abstract][Full Text] [Related]
29. Schisandra fruits for the management of drug-induced liver injury in China: A review.
Zhu P; Li J; Fu X; Yu Z
Phytomedicine; 2019 Jun; 59():152760. PubMed ID: 31004881
[TBL] [Abstract][Full Text] [Related]
30.
Jiang B; Yan LJ; Wu Q
DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
[TBL] [Abstract][Full Text] [Related]
31. Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science.
Türková A; Zdrazil B
Comput Struct Biotechnol J; 2019; 17():390-405. PubMed ID: 30976382
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.
Hu YH; Zhou L; Wang SS; Jing X; Guo HL; Sun F; Zhang Y; Chen F; Xu J; Ji X
Curr Pharm Des; 2019; 25(6):627-634. PubMed ID: 30931851
[TBL] [Abstract][Full Text] [Related]
33. Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high-dose cyclophosphamide-induced nephrotoxicity and neurotoxicity in rats.
Chen L; Xiong X; Hou X; Wei H; Zhai J; Xia T; Gong X; Gao S; Feng G; Tao X; Zhang F; Chen W
Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):142-151. PubMed ID: 30793490
[TBL] [Abstract][Full Text] [Related]
34. Systematically identifying the hepatoprotective ingredients of schisandra lignan extract from pharmacokinetic and pharmacodynamic perspectives.
Kang D; Shao Y; Zhu Z; Yin X; Shen B; Chen C; Xu Y; Shen J; Li H; Li X; Xie L; Wang G; Liang Y
Phytomedicine; 2019 Feb; 53():182-192. PubMed ID: 30668398
[TBL] [Abstract][Full Text] [Related]
35. Enantioselective Drug Recognition by Drug Transporters.
Uwai Y
Molecules; 2018 Nov; 23(12):. PubMed ID: 30467304
[TBL] [Abstract][Full Text] [Related]
36. The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases.
Wu YJ; Wang C; Wei W
Biomed Pharmacother; 2018 Sep; 105():870-878. PubMed ID: 30021380
[TBL] [Abstract][Full Text] [Related]
37. Transporter-mediated interaction of indican and methotrexate in rats.
Lin SP; Yu CP; Hou YC; Huang CY; Ho LC; Chan SL
J Food Drug Anal; 2018 Apr; 26(2S):S133-S140. PubMed ID: 29703382
[TBL] [Abstract][Full Text] [Related]
38. Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.
Lozano E; Briz O; Macias RIR; Serrano MA; Marin JJG; Herraez E
J Pers Med; 2018 Apr; 8(2):. PubMed ID: 29659532
[TBL] [Abstract][Full Text] [Related]
39. Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor
Wang L; Ma L; Lin Y; Liu X; Xiao L; Zhang Y; Xu Y; Zhou H; Pan G
Mol Pharmacol; 2018 Jun; 93(6):563-574. PubMed ID: 29618584
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Zhang H; Bu F; Li L; Jiao Z; Ma G; Cai W; Zhuang X; Lin HS; Shin JG; Xiang X
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):331-340. PubMed ID: 28945011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
